Aaron covers what's exciting and new in the world of home entertainment and streaming TV. Previously, he wrote about entertainment for places like Rotten Tomatoes, Inverse, TheWrap and The Hollywood ...
In a market stuffed with Metroidvanias, there are a few reasons Hollow Knight and the sequel, Hollow Knight: Silksong, stand out among the crowd. One of the leading factors is Team Cherry’s commitment ...
Fed Chair Jerome Powell was speaking Tuesday at an economic conference. Photo: Hannah Beier/Bloomberg News Federal Reserve Chair Jerome Powell left the central bank on track to reduce interest rates ...
With the official release of Hades 2 from early access to 1.0, we finally have what we have all been waiting for. The elusive true ending. The true ending is easily the best new addition introduced to ...
Diego Pineda has been a devout storyteller his whole life. He has self-published a fantasy novel and a book of short stories, and is actively working on publishing his second novel. A lifelong fan of ...
Florida lawmakers are considering a proposal to eliminate or significantly reduce property taxes for homeowners. Replacing lost property tax revenue would likely require raising other taxes, such as ...
Penn State quarterback Drew Allar, a potential first-round pick in the 2026 NFL draft, suffered a season-ending injury late in the fourth quarter of today’s loss to Northwestern. Allar ran the ball ...
“The Woman in Cabin 10” is now streaming on Netflix and, like many movie adaptations of books, it makes some key changes — particularly when it comes to the twist of the story. This perhaps goes ...
Editor's note: The following contains spoilers for 'Bring Her Back'2025 has been a great year for horror. Zach Cregger’s Weapons blew audiences away while introducing Amy Madigan’s instant icon, Aunt ...
The penultimate episode of Peacemaker‘s sophomore outing acts a lot like the end of Act II in a movie, putting the titular anti-hero up against insurmountable odds by putting him in A.R.G.U.S. custody ...
Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...